HCA Healthcare shareholders re-elect all nine director nominees; reject two shareholder proposals at 2026 annual meeting

HCA Healthcare, Inc.

All nine director nominees elected; votes for ranged from 173.1M (DeParle) to 193.7M (Hazen) shares.
Ratification of Ernst & Young as independent auditor for FY2026 passed with 192.7M for, 17.0M against.
Non-binding advisory vote on named executive officer compensation approved with 182.4M for, 12.8M against.
Shareholder proposal on healthcare consequences report rejected: 21.2M for, 173.3M against.
Shareholder proposal on right to act by written consent rejected: 42.8M for, 152.1M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.